Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung CancerMassimo Di Maïo, Cesare Gridelli, Fortunato Ciardiello et al.|Journal of Thoracic Oncology|2012Cited by 26
The role of coronary artery calcification score in lung cancer patientsValerio Nardone, Salvatore Cappabianca, Alfonso Reginelli et al.|European Journal of Radiology|2021Cited by 3